237 related articles for article (PubMed ID: 34272707)
1. How Science Is Driving Regulatory Guidances.
Yang X; Fan J; Zhang L
Methods Mol Biol; 2021; 2342():595-629. PubMed ID: 34272707
[TBL] [Abstract][Full Text] [Related]
2. Contribution of metabolites to P450 inhibition-based drug-drug interactions: scholarship from the drug metabolism leadership group of the innovation and quality consortium metabolite group.
Yu H; Balani SK; Chen W; Cui D; He L; Humphreys WG; Mao J; Lai WG; Lee AJ; Lim HK; MacLauchlin C; Prakash C; Surapaneni S; Tse S; Upthagrove A; Walsky RL; Wen B; Zeng Z
Drug Metab Dispos; 2015 Apr; 43(4):620-30. PubMed ID: 25655830
[TBL] [Abstract][Full Text] [Related]
3. 2020 FDA Drug-drug Interaction Guidance: A Comparison Analysis and Action Plan by Pharmaceutical Industrial Scientists.
Sudsakorn S; Bahadduri P; Fretland J; Lu C
Curr Drug Metab; 2020; 21(6):403-426. PubMed ID: 32562522
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cytochrome P450-mediated drug-drug interactions based on the strategies recommended by regulatory authorities.
Kosugi Y; Hirabayashi H; Igari T; Fujioka Y; Hara Y; Okuda T; Moriwaki T
Xenobiotica; 2012 Feb; 42(2):127-38. PubMed ID: 22117526
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition of human liver cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes by rose bengal: system-dependent effects on inhibitory potential.
Kazmi F; Haupt LJ; Horkman JR; Smith BD; Buckley DB; Wachter EA; Singer JM
Xenobiotica; 2014 Jul; 44(7):606-14. PubMed ID: 24405273
[TBL] [Abstract][Full Text] [Related]
7. Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4.
Brown HS; Galetin A; Hallifax D; Houston JB
Clin Pharmacokinet; 2006; 45(10):1035-50. PubMed ID: 16984215
[TBL] [Abstract][Full Text] [Related]
8. Predicting the effect of cytochrome P450 inhibitors on substrate drugs: analysis of physiologically based pharmacokinetic modeling submissions to the US Food and Drug Administration.
Wagner C; Pan Y; Hsu V; Grillo JA; Zhang L; Reynolds KS; Sinha V; Zhao P
Clin Pharmacokinet; 2015 Jan; 54(1):117-27. PubMed ID: 25260695
[TBL] [Abstract][Full Text] [Related]
9. System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome P450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: human hepatocytes versus liver microsomes versus recombinant enzymes.
Parkinson A; Kazmi F; Buckley DB; Yerino P; Ogilvie BW; Paris BL
Drug Metab Pharmacokinet; 2010; 25(1):16-27. PubMed ID: 20208386
[TBL] [Abstract][Full Text] [Related]
10. Everolimus-inhibited multiple isoforms of UDP-glucuronosyltransferases (UGTs).
Du Z; Wang G; Cao YF; Hu CM; Yang K; Liu YZ; Zhang CZ; Zhang WH; Zhu ZT; Sun HZ; Sun XY; Hong M; Fang ZZ
Xenobiotica; 2018 May; 48(5):452-458. PubMed ID: 28548030
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Drug-Drug Interaction Evaluation of GalNAc Conjugated siRNAs Against CYP450 Enzymes and Transporters.
Ramsden D; Wu JT; Zerler B; Iqbal S; Jiang J; Clausen V; Aluri K; Gu Y; Dennin S; Kim J; Chong S
Drug Metab Dispos; 2019 Oct; 47(10):1183-1194. PubMed ID: 31270142
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory Effects of Selected Antituberculosis Drugs on Common Human Hepatic Cytochrome P450 and UDP-glucuronosyltransferase Enzymes.
Cao L; Greenblatt DJ; Kwara A
Drug Metab Dispos; 2017 Sep; 45(9):1035-1043. PubMed ID: 28663285
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolism of eupatilin by multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes.
Lee HS; Ji HY; Park EJ; Kim SY
Xenobiotica; 2007 Aug; 37(8):803-17. PubMed ID: 17701830
[TBL] [Abstract][Full Text] [Related]
14. A perspective on the contribution of metabolites to drug-drug interaction potential: the need to consider both circulating levels and inhibition potency.
Yu H; Tweedie D
Drug Metab Dispos; 2013 Mar; 41(3):536-40. PubMed ID: 23143892
[TBL] [Abstract][Full Text] [Related]
15. Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate glucuronosyltransferases.
Kim SB; Kim KS; Kim DD; Yoon IS
Biomed Pharmacother; 2019 Feb; 110():111-117. PubMed ID: 30466000
[TBL] [Abstract][Full Text] [Related]
16. Drug-drug interactions in the metabolism of imidafenacin: role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes.
Kanayama N; Kanari C; Masuda Y; Ohmori S; Ooie T
Xenobiotica; 2007 Feb; 37(2):139-54. PubMed ID: 17484517
[TBL] [Abstract][Full Text] [Related]
17. Reversible Mechanisms of Enzyme Inhibition and Resulting Clinical Significance.
Ring B; Wrighton SA; Mohutsky M
Methods Mol Biol; 2021; 2342():29-50. PubMed ID: 34272690
[TBL] [Abstract][Full Text] [Related]
18. In vitro drug-drug interaction studies with febuxostat, a novel non-purine selective inhibitor of xanthine oxidase: plasma protein binding, identification of metabolic enzymes and cytochrome P450 inhibition.
Mukoyoshi M; Nishimura S; Hoshide S; Umeda S; Kanou M; Taniguchi K; Muroga H
Xenobiotica; 2008 May; 38(5):496-510. PubMed ID: 18421623
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the inhibition risk of paris saponins, bioactive compounds from Paris polyphylla, on CYP and UGT enzymes via cocktail inhibition assays.
Luo H; Xu Y; Sun D; Cheng Y; Sun Z; Gao J; Zhang Y; Wang X
Regul Toxicol Pharmacol; 2020 Jun; 113():104637. PubMed ID: 32145316
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
Lee B; Ji HK; Lee T; Liu KH
Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
